Clinical Trials Browser

Anemia, Aplastic, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

NCT00698685 2017-03-31

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Phase 2 Terminated

14 enrolled 7 charts

GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00058825 2016-11-07

HIMSUM

Phase 1/2 Terminated

27 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Phase 1/2 Terminated

4 enrolled 8 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00578539 2016-04-22

REGALE

Phase NA Terminated

24 enrolled 7 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders

NCT00578903 2016-04-22

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Phase 2 Terminated

22 enrolled 11 charts

Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

NCT00587847 2015-10-15

Campath Maintenance in Chronic Lymphocytic Leukemia

Phase NA Terminated

12 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00771602 2015-06-23

Alemtuzumab + Rituximab Consolidation in CLL

Phase 2 Terminated

1 enrolled 2 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00262925 2015-05-05

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2 Terminated

12 enrolled 6 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00818961 2013-12-18

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Phase 2 Terminated

36 enrolled 16 charts

LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00453193 2012-08-07

Alemtuzumab and Pentostatin In T-cell Neoplasms

Phase 2 Terminated

26 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

Phase 2 Terminated

27 enrolled 5 charts

Lymphoid

Lymphoma, Lymphoma, T-Cell

Clinical Trials

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia

THALLO

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

HIMSUM

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

REGALE

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Campath Maintenance in Chronic Lymphocytic Leukemia

Alemtuzumab + Rituximab Consolidation in CLL

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Alemtuzumab and Pentostatin In T-cell Neoplasms

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma